One non-believer: Response to "Obviously Nine Believers: Actionable Germline Genetic Variants for Pre-emptive Pharmacogenetic Testing".

van der Wouden, Cathelijne H; van Rhenen, Mandy H; Jama, Wafa O M; Ingelman-Sundberg, Magnus; Lauschke, Volker M; Konta, Lidija; Schwab, Matthias; Swen, Jesse J; Guchelaar, Henk-Jan.

Afiliação

van der Wouden CH; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
van Rhenen MH; Leiden Network for Personalised Therapeutics, Leiden, The Netherlands.
Jama WOM; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands.
Ingelman-Sundberg M; Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands.
Lauschke VM; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Biomedicum 5B Karolinska Institute, Stockholm, Sweden.
Konta L; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Biomedicum 5B Karolinska Institute, Stockholm, Sweden.
Schwab M; bio.logis Center for Human Genetics, Frankfurt am Main, Germany.
Swen JJ; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Guchelaar HJ; Department of Clinical Pharmacology and Departments of Biochemistry and Pharmacy, University Tuebingen, Tuebingen, Germany.

Basic Clin Pharmacol Toxicol ; 126(1): 7-8, 2020 Jan.

Article em En | MEDLINE | ID: mdl-31670867

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article